The potential of proton beam radiation therapy in lung cancer (including mesothelioma)

Acta Oncologica

Volumn 44, Issue 8, 2005, Pages 881-883

  Bjelkengren, Göran ^a   Glimelius, Bengt ^b,c  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; BEAM THERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SIZE; CLINICAL RESEARCH; HUMAN; LUNG NON SMALL CELL CANCER; MEDICAL ASSESSMENT; MESOTHELIOMA; PRIORITY JOURNAL; PROTON RADIATION; RADIATION DOSE; RADIATION DOSE FRACTIONATION; REVIEW;

HUMANS; LUNG NEOPLASMS; MESOTHELIOMA; PROTONS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; SWEDEN;

EID: 28844451119     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841860500355975     Document Type: Review

References (28)

1. Cancer Incidence in Sweden. Epidemiologiskt Centrum 2003; www.sos.se.
2. Talbäck M, Stenbeck M, Rosén M, Glimelius B. Cancer survival in Sweden. Acta Oncol 2003;42:637-59.
3. The International Adjuvant Lung Cancer Trial Collaborative Group. Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non-Small-Cell Lung Cancer. N Engl J Med 2004;350:351-60.
4. Douillard J-Y, Rosell R, Delena M, Legroumellec A, Torres A, Carpagnano F, et al. ANITA: Phase III adjuvant vinorelbine and cisplatin versus observation in completely resected (stage I-III) non-small cell lung cancer patients. Final results after 70-month median follow-up. J Clin Oncol 2005;23(Suppl 16S):624s.abstract.
5. Winton T, Livingston R, Johnson D, Rigas J, Johnston M, Butts C, et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 2005;352:2589-97.
6. Burdett S, Stewart L. Postoperative radiotherapy in non-small-cell lung cancer: update of an individual patient data meta-analysis. Lung Cancer 2005;47:81-3.
7. Chahinian AP, Harvey IP. Malignant Mesothelioma. In: Holland JF, Frei E, editors. Cancer Medicine, volume 6. London: BC Decker Inc; 2003. p. 1447-66.
8. Sirzén F, Kjellen E, Sörenson S, Cavallin-Ståhl E. A systematic overview of radiation therapy effects in non-small cell lung cancer. Acta Oncol 2003;42:493-515.
9. Rowell NP, Williams CJ. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review. Thorax 2001;56:628-38.
10. Zimmermann FB, Bamberg M, Molls M, Jeremic B. Radiation therapy alone in early stage non-small cell lung cancer. Semin Surg Oncol 2003;21:91-7.
11. Uematsu M, Shioda A, Suda A, Fukui T, Ozeki Y, Hama Y, et al. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience. Int J Radiat Oncol Biol Phys 2001;51:666-70.
12. Timmerman R, Papiez L, McGarry R, Likes L, DesRosiers C, Frost S, et al. Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 2003;124:1946-55.
13. Bush DA, Slater JD, Bonnet R, Cheek GA, Dunbar RD, Moyers M, et al. Proton-beam radiotherapy for early-stage lung cancer. Chest 1999;116:1313-9.
14. Bonnet RB, Bush D, Cheek GA, Slater JD, Panossian D, Franke C, et al. Effects of proton and combined proton/photon beam radiation on pulmonary function in patients with resectable but medically inoperable non-small cell lung cancer. Chest 2001;120:1803-10.
15. Moyers MF, Miller DW, Bush DA, Slater JD. Methodologies and tools for proton beam design for lung tumors. Int J Radiat Oncol Biol Phys 2001;49:1429-38.
16. Bush DA, Slater JD, Shin BB, Cheek G, Miller DW, Slater JM. Hypofractionated proton beam radiotherapy for stage I lung cancer. Chest 2004;126:1198-203.
17. Koto M, Miyamoto T, Yamamoto N, Nishimura H, Yamada S, Tsujii H. Local control and recurrence of stage I non-small cell lung cancer after carbon ion radiotherapy. Radiother Oncol 2004;71:147-56.
18. Miyamoto T, Yamamoto N, Nishimura H, Koto M, Tsujii H, Mizoe JE, et al. Carbon ion radiotherapy for stage I non-small cell lung cancer. Radiother Oncol 2003;66:127-40.
19. Lee C, Tait D, Nahum A, Webb S. Comparison of proton therapy and conformal x-ray therapy in non-small cell lung cancer (NSCLC). Br J Radiat 1999;72:1078-84.
20. Möller TR, Brorsson B, Ceberg J, Frodin JE, Lindholm C, Nylen U, et al. A prospective survey of radiotherapy practice 2001 in Sweden. Acta Oncol 2003;42:387-410.
21. Fowler JF. What can we expect from dose escalation using proton beams? Clin Oncol (R Coll Radiol) 2003;15:S10-5.
22. Turrisi AT, 3rd. It's about time, or is it volume, fractionation, or technique? Int J Radiat Oncol Biol Phys 1996;36:753-5.
23. Liengswangwong V, Bonner JA. Point: the potential importance of elective nodal irradiation in the treatment of non-small cell lung cancer. Semin Radiat Oncol 2000;10:308-14.
24. Forssell-Aronsson E, Kjellén E, Mattsson S, Hellström M. and the Swedish Cancer Society Investigation Group. Medical imaging for improved tumour characterisation, delineation and treatment verification. Acta Oncol 2002;41:604-14.
25. Black QC, Grills IS, Kestin LL, Wong CY, Wong JW, Martinez AA, et al. Defining a radiotherapy target with positron emission tomography. Int J Radiat Oncol Biol Phys 2004;60:1272-82.
26. Brahme A. Biologically optimized 3-dimensional in-vivo predictive assay based radiation therapy using PET-CT imaging. Acta Oncol 2003;42:123-36.
27. Svensson H, Möller T. Developments in radiotherapy. Acta Oncol 2003;42:430-42.
28. Alberts AS, Falkson G, Goedhals L, Vorobiof DA, Van der Merwe CA. Malignant pleural mesothelioma: a disease unaffected by current therapeutic maneuvers. J Clin Oncol 1988;6:527-35.